ACSL4 and prostate cancer: For instance, lncRNA NEAT1 have been identified to promote proliferation, invasion and docetaxel resistance in prostate cancer (PCa) by releasing miR‐34a‐5p and miR‐204‐5p‐mediated repression of ACSL4 expression.[152] Second, ACSL4 acts as a positive regulator in ferroptosis, a novel programmed cell death characterized by the accumulation of iron and lipid peroxidation.